Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

WHO São Tomé and Principe Biennial Report 2024–2025

WHO São Tomé and Principe Biennial Report 2024–2025 afonsoe@who.int Tue, 29/09/2026 - 16:26 The WHO São Tomé and Principe Biennial Report 2024–2025 highlights the progress achieved by São Tomé and Príncipe in strengthening its health system through close collaboration between the Ministry of Health, WHO, and development partners. During the biennium, key reforms enhanced health governance,…

The WHO São Tomé and Principe Biennial 2025 highlights significant progress made by the small island nation of São Tomé and Príncipe in fortifying its health system. This is achieved through a collaborative effort between the Ministry of Health, the World Health Organization (WHO), and various development partners. Over the two-year period, numerous reforms were implemented to bolster health governance, primary health care, health financing, and the country's readiness for and response to public health emergencies.

Among the major achievements, São Tomé and Príncipe adopted its first-ever National Health Financing Strategy, running from 2025 to 2032. The country also witnessed vaccination coverage surpassing the 95% mark. District health management was strengthened, marking a substantial improvement in healthcare delivery. Furthermore, significant strides were taken towards the eradication of lymphatic filariasis, a parasitic disease.

These accomplishments underscore a steadfast dedication to advancing Universal Health Coverage (UHC) and fostering a more resilient, equitable, and sustainable health system in São Tomé and Príncipe. The complete report can be accessed in the provided PDF document.

Written by urgent.news from WHO Africa's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at afro.who.int →

More in Health & Medicine

How Cells Respond Differently to a Cancer-Causing Gene

Chemotherapies frequently cause cancer cells to enter senescence, but do not fully eliminate these cells. Therefore, it is useful to target these therapy-induced senescent cells with senolytics that…

  • A single cancer-causing gene can trigger varied cellular responses.
  • Some responses inhibit tumor growth, while others promote tumor development.
  • Researchers used zebrafish model to discover different types of cellular senescence.

More from Tuesday 29 September →